Can I start mirtazapine (Remeron) at a dose of 30 mg?

No, Do Not Start Mirtazapine at 30 mg

You should start mirtazapine at 7.5 mg at bedtime and titrate upward based on response and tolerability. Starting at 30 mg bypasses the recommended dose escalation strategy and increases the risk of adverse effects without established benefit.

Evidence-Based Starting Dose

Multiple guidelines consistently recommend a low starting dose:

• The 2002 Alzheimer's Disease Management Guidelines specify an initial dose of 7.5 mg at bedtime, with a maximum of 30 mg at bedtime 1. This represents the standard approach even in specialized populations.

• The 2021 AGA Clinical Practice Update on gastrointestinal pain management recommends starting mirtazapine at 15 mg once daily, titrating to a maximum of 45 mg once daily according to response and tolerability 2. Even this higher starting dose of 15 mg is still half of the 30 mg you're considering.

• The 2016 NCCN Palliative Care Guidelines recommend mirtazapine 7.5-30 mg PO at bedtime for insomnia 3, indicating the dose range rather than a fixed starting point.

• The FDA-approved prescribing information does not specify a mandatory starting dose but emphasizes individualized dosing 4. However, the clinical trial data and guidelines consistently favor lower initial doses.

Why Starting Lower Is Critical

Dose titration allows assessment of tolerability before escalating: The most common adverse effects of mirtazapine—somnolence, increased appetite, and weight gain—are dose-related 2. Starting at 30 mg immediately exposes patients to maximum sedation risk without the opportunity to assess individual sensitivity.

Research demonstrates that early dose escalation may benefit non-responders, but this requires first establishing a baseline response: A 2015 study found that increasing from 15 mg to 30 mg in patients without initial improvement at week 1 resulted in significantly greater HDRS-17 score reduction compared to staying at 15 mg 5. However, increasing beyond 30 mg to 45 mg showed no additional benefit 5. This suggests that 30 mg may be an effective target dose, but reaching it through titration is more rational than starting there.

Practical Dosing Algorithm

1. Start at 7.5-15 mg at bedtime (7.5 mg preferred in elderly, debilitated, or those with hepatic/renal impairment 1)

2. Assess response and tolerability at 1 week:

   • If well-tolerated but insufficient response, increase to 15 mg (if started at 7.5 mg) or 30 mg (if started at 15 mg)
   • If excessive sedation or other adverse effects, maintain current dose or reduce

3. Reassess at 2-4 weeks:

   • If inadequate response at 15 mg, increase to 30 mg
   • Maximum dose is 45 mg, but evidence for benefit beyond 30 mg is limited 5

4. Allow 4-8 weeks for full therapeutic trial 1

Special Populations Requiring Lower Starting Doses

Elderly patients: The 2015 American Family Physician guidelines recommend starting at approximately 50% of the adult dose in older adults due to increased risk of adverse drug reactions 6. This would translate to 7.5 mg or less.

Hepatic or renal impairment: Mirtazapine clearance is reduced in moderate to severe renal or hepatic impairment, leading to increased plasma levels 4. Dose reduction is necessary in these populations.

Common Pitfalls to Avoid

• Don't assume higher doses work faster: While one study suggested mirtazapine may have faster onset than some SSRIs 7, this doesn't justify starting at maximum doses. The speed advantage was observed with standard dosing protocols.

• Don't confuse maximum dose with starting dose: The 30 mg maximum in some guidelines 1 refers to the upper limit after titration, not the initial dose.

• Don't overlook the paradoxical dose-response relationship: Mirtazapine's antihistaminic effects (causing sedation) are more prominent at lower doses, while noradrenergic effects become more prominent at higher doses 8. Starting at 30 mg may cause excessive sedation without allowing assessment of the optimal balance for the individual patient.

In summary, starting mirtazapine at 30 mg contradicts established guidelines and bypasses the opportunity to optimize dosing based on individual response and tolerability. Begin at 7.5-15 mg and titrate upward as clinically indicated.